Lixte Biotech Hlds
(LIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,088 | 5,353 | 6,562 | 7,736 | 3,778 |
| Other current assets | 131 | 147 | 147 | 147 | 147 |
| TOTAL | $4,331 | $5,561 | $6,820 | $8,024 | $4,107 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 11 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $11 |
| Total Assets | $4,331 | $5,561 | $6,820 | $8,024 | $4,118 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 224 | 231 | 307 | 373 | 370 |
| Other current liabilities | 26 | 165 | 101 | 159 | 275 |
| TOTAL | $250 | $396 | $408 | $532 | $645 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $250 | $396 | $408 | $532 | $645 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,666 | 1,666 | 1,665 | 1,665 | 1,665 |
| Common Shares | 2 | 0 | 2 | 2 | 1 |
| Retained earnings | -44,762 | -43,395 | -41,763 | -40,285 | -38,739 |
| TOTAL | $4,081 | $5,165 | $6,411 | $7,492 | $3,473 |
| Total Liabilities And Equity | $4,331 | $5,561 | $6,819 | $8,024 | $4,118 |